Archigen Biotech

Samsung Biologics, AstraZeneca to dissolve biosimilar JV, scrap Rituxan copy program: report
Fierce Pharma
Thu, 11/19/20 - 08:29 pm
Samsung BioLogics
AstraZeneca
Rituxan
Roche
biosimilars
Archigen Biotech